We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plant Health Care Plc | LSE:PHC | London | Ordinary Share | GB00B01JC540 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.12 | 3.46% | 3.59 | 3.30 | 3.86 | 3.62 | 3.44 | 3.56 | 675,665 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pesticides, Agric Chems, Nec | 11.77M | -9.48M | -0.0278 | -1.30 | 12.36M |
TIDMPHC
Plant Health Care PLC
11 December 2020
Reach
11 December 2020
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
Investor Presentation
Plant Health Care (R) (AIM: PHC.L) , a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce Dr. Christopher Richards, CEO, Zhongmin Wei, CSO, and Mark Turner, Director of Licensing, will provide a live presentation relating to its pipeline of novel plant response elicitor ("PREtec") products via the Investor Meet Company platform on 17 December 2020 at 3:00 p.m. (BST).
The Company is committed to ensuring that there are appropriate communication structures for all elements of its shareholder base so that its strategy, business model and performance are clearly understood.
Highlights
- The online presentation is open to all existing and potential shareholders.
- Questions can be submitted pre-event via your IMC dashboard or any time during the live presentation via the "Ask a Question" function. Although the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the Investor Meet Company platform.
- Investors can sign up to Investor Meet Company for free and add to meet Plant Health Care plc via: https://www.investormeetcompany.com/plant-health-care-plc/register-investor
Investor feedback can also be submitted directly to management post-event to ensure the Company can understand the views of all elements of its shareholder base. Investors who have already registered and added to meet the Company will be automatically invited.
For further information, please contact:
Plant Health Care plc
Chris Richards, CEO, Tel: +1 919 926 1600
Arden Partners plc - Nomad & Broker
John Llewellyn-Lloyd / Ben Cryer Tel: +44 (0) 20 7614 5900
Company website: www.planthealthcare.com
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAGPGQGPUPUGMU
(END) Dow Jones Newswires
December 11, 2020 02:00 ET (07:00 GMT)
1 Year Plant Health Care Chart |
1 Month Plant Health Care Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions